- Report
- June 2026
- 110 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- July 2026
- 143 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Clinical Trials
- April 2026
- 280 Pages
Global
From €2822EUR$3,000USD£2,354GBP
- Report
- April 2026
- 280 Pages
Global
From €4703EUR$5,000USD£3,923GBP
- Report
- January 2026
- 450 Pages
Global
From €4703EUR$5,000USD£3,923GBP
- Report
- January 2026
- 450 Pages
Global
From €4703EUR$5,000USD£3,923GBP
- Report
- January 2026
- 250 Pages
Global
From €3292EUR$3,500USD£2,746GBP
- Report
- May 2026
- 150 Pages
Global
From €2538EUR$2,699USD£2,118GBP
- Report
- April 2026
- 146 Pages
Global
From €3761EUR$3,999USD£3,137GBP
- Report
- April 2026
- 145 Pages
Global
From €3761EUR$3,999USD£3,137GBP
- Report
- July 2026
- 200 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- May 2026
- 152 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- November 2026
- 160 Pages
Global
From €3122EUR$3,320USD£2,605GBP
€3903EUR$4,150USD£3,256GBP
- Report
- March 2026
- 84 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- January 2026
- 82 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- October 2025
- 442 Pages
Global
From €4513EUR$4,799USD£3,765GBP
- Report
- November 2026
Global
From €750EUR$854USD£648GBP
- Report
- July 2020
- 1200 Pages
Japan
From €2822EUR$3,000USD£2,354GBP
- Clinical Trials
- February 2018
- 225 Pages
Global
From €2257EUR$2,400USD£1,883GBP
- Report
- November 2024
- 600 Pages
Global
From €3104EUR$3,300USD£2,589GBP

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient.
The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more